Peptide questions · SLU-PP-332
How long does SLU-PP-332 take to work?
Reviewed Evidence: EmergingPublished by PepVault
SLU-PP-332’s onset is unknown in people, its peak effect comes at unknown in people, and its typical duration is about 8 weeks (community runs), by the library’s timeline (backed by preliminary research).
The timeline’s basis: Mouse and cell studies only; no human studies. Community reports are sparse.
SLU-PP-332 week by week
The library places three of its research notes on SLU-PP-332 on the days they cover, from day 1 to day 84: 3 on animal studies.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–14 (weeks 1–2) | Week one: an honest baseline | Animal study |
| Days 15–56 (weeks 3–8) | How it burns fat | Animal study |
| Days 57–84 (weeks 9–12) | Weeks 8 to 12: where community runs pause | Animal study |

Model. Individual results vary.
The SLU-PP-332 timeline’s milestones
The library’s timeline for SLU-PP-332 marks 3 points from week 1 to week 8, backed by preliminary research overall.
- Week 1: Commonly reported: some notice cardio feeling easier within a week or two; many notice nothing
- Week 2: In mice, endurance rose after a week of twice-daily injections, and grip strength after two
- Week 8: Community runs commonly last about 8 weeks, then pause for about 4
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why SLU-PP-332 takes that long
The library states no half-life with a number for SLU-PP-332 (it says: “Unknown: never measured in people; in mice, levels in muscle were about three times those in blood 2 hours after an injection”), so this page can’t work out a build-up; the timing rests on the notes above.
SLU-PP-332 against other metabolic & GLP-1 compounds
The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, SLU-PP-332 among them; none of the others shares its onset of unknown in people.
| Compound | Onset | Peak effect |
|---|---|---|
| Semaglutide | Days–2 weeks | 60–68 weeks |
| Tirzepatide | Days–2 weeks | 72+ weeks |
| Retatrutide | Days–2 weeks | 48+ weeks |
| Dulaglutide | Days–2 weeks | 24–52 weeks (glucose) |
| Exenatide | First dose (after-meal glucose) | 24–30 weeks (HbA1c) |
| Setmelanotide | 1–2 weeks (hunger) | 52 weeks (BMI) |
| Orforglipron | Days–2 weeks | 72 weeks (trial endpoint) |
| Survodutide | Days–2 weeks | 76 weeks (trial endpoint) |
| Mazdutide | Days–2 weeks | 48–60 weeks |
| Pemvidutide | Days–2 weeks | 48+ weeks |
| Cagrilintide | Days–2 weeks | 26–68 weeks (trial endpoints) |
| Pramlintide | First meal (fullness, after-meal glucose) | 16–52 weeks (weight, HbA1c) |
| CagriSema | Days–2 weeks | 68+ weeks |
| Eloralintide | Days–2 weeks | 48 weeks (phase 2 endpoint) |
| Petrelintide | Days–2 weeks | 42 weeks (phase 2, still falling) |
| Amycretin | Days–2 weeks | 36 weeks (longest trial so far) |
| VK2735 | Days–2 weeks | 78 weeks (phase 3 endpoint, not yet read out) |
| Enicepatide | Days–2 weeks | 48 weeks (phase 2 endpoint, no plateau) |
| Ecnoglutide | Days–2 weeks | 48 weeks (phase 3, no plateau) |
| Efinopegdutide | Weeks | 24–52 weeks (trial endpoints) |
| SLU-PP-332 | Unknown in people | Unknown in people |
Questions people ask
How long does SLU-PP-332 take to work?
SLU-PP-332’s onset is unknown in people, its peak effect comes at unknown in people, and its typical duration is about 8 weeks (community runs), by the library’s timeline (backed by preliminary research).
When does SLU-PP-332 reach its peak effect?
By the library’s timeline, SLU-PP-332’s peak effect comes at unknown in people, backed by preliminary research.
How long is SLU-PP-332 usually run?
The library’s timeline gives SLU-PP-332’s typical duration as about 8 weeks (community runs); its cycle note says: Community runs commonly last about 8 weeks with about 4 weeks off; no study has tested any schedule in people.
What does the library say about the first days on SLU-PP-332?
Its first note on SLU-PP-332, for days 1–14 (weeks 1–2), is “Week one: an honest baseline”, resting on animal studies.